Literature DB >> 7639698

Association of a RING finger protein with the cytoplasmic domain of the human type-2 tumour necrosis factor receptor.

H Y Song1, D B Donner.   

Abstract

A human gene encoding a protein that specifically binds to the intracellular domain of the 75 kDa type-2 tumour necrosis factor (TNF) receptor (TNFR-2IC) has been identified using the yeast-based two-hybrid system. The N-terminal half of the TNF receptor-associated protein (TRAP) contains RING finger and zinc finger motifs often found in DNA-binding proteins including transcription factors. The 2.4 kb TRAP mRNA was barely detectable, if present at all, in lung, and variably expressed in heart, liver, placenta, brain, skeletal muscle, kidney and the pancreas; interestingly, the TRAP was more highly expressed in transformed cell lines than in normal tissues. This observation may be consistent with a role for this TRAP in promoting or regulating cellular proliferation. After in vitro transcription/translation and 35S labelling the TRAP was precipitated using a fusion protein consisting of glutathione S-transferase and the intracellular domain of TNFR-2 (TNFR-2IC), which showed that the two proteins directly interact in a mammalian cell-free system and also that identification of the TRAP was not an artifact of the two-hybrid system. By using truncated TNFR-2ICs for in vitro precipitation of 35S-TRAP, it was shown that the C-terminal half of the TNFR-2IC contains the domain necessary for interaction with TRAP. The TRAP identified in the present study shares considerable homology with, and may be the human homologue of, a mouse protein, TNF receptor-associated factor 2 (TRAF2), that binds mouse TNFR-2.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7639698      PMCID: PMC1135706          DOI: 10.1042/bj3090825

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  39 in total

1.  Both tumor necrosis factor receptor types mediate proliferative signals in human mononuclear cell activation.

Authors:  G Gehr; R Gentz; M Brockhaus; H Loetscher; W Lesslauer
Journal:  J Immunol       Date:  1992-08-01       Impact factor: 5.422

Review 2.  A novel zinc finger coiled-coil domain in a family of nuclear proteins.

Authors:  B A Reddy; L D Etkin; P S Freemont
Journal:  Trends Biochem Sci       Date:  1992-09       Impact factor: 13.807

Review 3.  Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions.

Authors:  J Vilcek; T H Lee
Journal:  J Biol Chem       Date:  1991-04-25       Impact factor: 5.157

4.  Expression of the types A and B tumor necrosis factor (TNF) receptors is independently regulated, and both receptors mediate activation of the transcription factor NF-kappa B. TNF alpha is not needed for induction of a biological effect via TNF receptors.

Authors:  H P Hohmann; M Brockhaus; P A Baeuerle; R Remy; R Kolbeck; A P van Loon
Journal:  J Biol Chem       Date:  1990-12-25       Impact factor: 5.157

5.  Antibodies to a soluble form of a tumor necrosis factor (TNF) receptor have TNF-like activity.

Authors:  H Engelmann; H Holtmann; C Brakebusch; Y S Avni; I Sarov; Y Nophar; E Hadas; O Leitner; D Wallach
Journal:  J Biol Chem       Date:  1990-08-25       Impact factor: 5.157

6.  The two different receptors for tumor necrosis factor mediate distinct cellular responses.

Authors:  L A Tartaglia; R F Weber; I S Figari; C Reynolds; M A Palladino; D V Goeddel
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

7.  A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins.

Authors:  C A Smith; T Davis; D Anderson; L Solam; M P Beckmann; R Jerzy; S K Dower; D Cosman; R G Goodwin
Journal:  Science       Date:  1990-05-25       Impact factor: 47.728

8.  The p70 tumor necrosis factor receptor mediates cytotoxicity.

Authors:  R A Heller; K Song; N Fan; D J Chang
Journal:  Cell       Date:  1992-07-10       Impact factor: 41.582

9.  Binding and regulation of cellular functions by monoclonal antibodies against human tumor necrosis factor receptors.

Authors:  M R Shalaby; A Sundan; H Loetscher; M Brockhaus; W Lesslauer; T Espevik
Journal:  J Exp Med       Date:  1990-11-01       Impact factor: 14.307

10.  Functional characterization of the human tumor necrosis factor receptor p75 in a transfected rat/mouse T cell hybridoma.

Authors:  P Vandenabeele; W Declercq; D Vercammen; M Van de Craen; J Grooten; H Loetscher; M Brockhaus; W Lesslauer; W Fiers
Journal:  J Exp Med       Date:  1992-10-01       Impact factor: 14.307

View more
  14 in total

1.  Tumor necrosis factor (TNF)-mediated kinase cascades: bifurcation of nuclear factor-kappaB and c-jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor-associated factor 2.

Authors:  H Y Song; C H Régnier; C J Kirschning; D V Goeddel; M Rothe
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

2.  A conserved family of cellular genes related to the baculovirus iap gene and encoding apoptosis inhibitors.

Authors:  C S Duckett; V E Nava; R W Gedrich; R J Clem; J L Van Dongen; M C Gilfillan; H Shiels; J M Hardwick; C B Thompson
Journal:  EMBO J       Date:  1996-06-03       Impact factor: 11.598

3.  Tumor necrosis factor receptor associated factor 2 is a mediator of NF-kappa B activation by latent infection membrane protein 1, the Epstein-Barr virus transforming protein.

Authors:  K M Kaye; O Devergne; J N Harada; K M Izumi; R Yalamanchili; E Kieff; G Mosialos
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

4.  The tumor necrosis factor-inducible zinc finger protein A20 interacts with TRAF1/TRAF2 and inhibits NF-kappaB activation.

Authors:  H Y Song; M Rothe; D V Goeddel
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

5.  Mutational analysis of ICP0R, a transrepressor protein created by alternative splicing of the ICP0 gene of herpes simplex virus type 1.

Authors:  S J Spatz; E C Nordby; P C Weber
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

6.  I-TRAF is a novel TRAF-interacting protein that regulates TRAF-mediated signal transduction.

Authors:  M Rothe; J Xiong; H B Shu; K Williamson; A Goddard; D V Goeddel
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-06       Impact factor: 11.205

7.  Induction of nuclear factor kappaB by the CD30 receptor is mediated by TRAF1 and TRAF2.

Authors:  C S Duckett; R W Gedrich; M C Gilfillan; C B Thompson
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

8.  Identification of five genes in endoplasmic reticulum (ER) stress-apoptosis pathways in yellow catfish Pelteobagrus fulvidraco and their transcriptional responses to dietary lipid levels.

Authors:  Dian-Guang Zhang; Jie Cheng; Zhi-Peng Tai; Zhi Luo
Journal:  Fish Physiol Biochem       Date:  2019-03-07       Impact factor: 2.794

9.  Tumor necrosis factor receptor-associated factor (TRAF)-1, TRAF-2, and TRAF-3 interact in vivo with the CD30 cytoplasmic domain; TRAF-2 mediates CD30-induced nuclear factor kappa B activation.

Authors:  S Ansieau; I Scheffrahn; G Mosialos; H Brand; J Duyster; K Kaye; J Harada; B Dougall; G Hübinger; E Kieff; F Herrmann; A Leutz; H J Gruss
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

Review 10.  Hodgkin's lymphoma and CD30 signal transduction.

Authors:  Ryouichi Horie; Masaaki Higashihara; Toshiki Watanabe
Journal:  Int J Hematol       Date:  2003-01       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.